Clinical Trials › NCT04879628
Active, Not RecruitingPhase 2
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
Sponsored by Sanofi
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 129
Target enrollment
4
U.S. states
Jun 2021
Start date
Aug 2027
Expected completion
Interventions / Treatments
SAR441344 IVplacebo IVSAR441344 SCplacebo SCMRI contrast-enhancing preparations
Conditions studied
Multiple Sclerosis
Where this trial is running (4 sites)
Participating MS centers on MS Buddy (4)
Atrium Health Neurosciences Institute
Charlotte, NC
Charlotte, NC
USF Multiple Sclerosis Center
Tampa, FL
Tampa, FL
Center for Neurology and Spine
Phoenix, AZ
Phoenix, AZ
MS centers in Arizona
Compare treatment centers near a trial site by center type, providers and trials.
View Arizona centersMore Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.